Springer Nature AG & Co. KGaA (ETR:SPG) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

It's been a pretty great week for Springer Nature AG & Co. KGaA (ETR:SPG) shareholders, with its shares surging 17% to €22.65 in the week since its latest quarterly results. Springer Nature KGaA reported in line with analyst predictions, delivering revenues of €476m and statutory earnings per share of €0.35, suggesting the business is executing well and in line with its plan. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Taking into account the latest results, the most recent consensus for Springer Nature KGaA from six analysts is for revenues of €1.92b in 2025. If met, it would imply a credible 2.4% increase on its revenue over the past 12 months. In the lead-up to this report, the analysts had been modelling revenues of €1.91b and earnings per share (EPS) of €1.30 in 2025. So we can see that while the consensus made no real change to its revenue estimates, it also no longer provides an earnings per share estimate. This suggests that revenues are what the market is focusing on after the latest results.

Check out our latest analysis for Springer Nature KGaA

We'd also point out that thatthe analysts have made no major changes to their price target of €28.01. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Springer Nature KGaA, with the most bullish analyst valuing it at €31.20 and the most bearish at €24.85 per share. This is a very narrow spread of estimates, implying either that Springer Nature KGaA is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Springer Nature KGaA's past performance and to peers in the same industry. The analysts are definitely expecting Springer Nature KGaA's growth to accelerate, with the forecast 4.9% annualised growth to the end of 2025 ranking favourably alongside historical growth of 1.4% per annum over the past year. Compare this with other companies in the same industry, which are forecast to grow their revenue 4.4% annually. Springer Nature KGaA is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.

The Bottom Line

The clear take away from these updates is that the analysts made no change to their revenue estimates for next year, with the business apparently performing in line with their models. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

At least one of Springer Nature KGaA's six analysts has provided estimates out to 2027, which can be seen for free on our platform here.

You still need to take note of risks, for example - Springer Nature KGaA has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.